drugset / Trial / NCT00500929

A Clinical Trial in Higher Risk Geriatric Patients Undergoing OHSP

NCT00500929 ↗

Phase 2 Completed 80 enrolled Cardiometabolics
RandomizedParallel-groupDouble-blindTreatment

Summary

To provide information on parameters needed to design a subsequent Phase III confirmatory trial and to assess the safety and efficacy of the acute use of CMI X-11S in high-risk geriatric patients undergoing open-heart surgical procedures (OHSP) requiring cardio-pulmonary bypass.

Timeline

Start
2007-07
Primary completion
2008-04
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium dichloroacetate Small molecule — —

Indications